These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9300699

  • 1. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM, Yang M, Milburn PJ, Baker R, Bhatnagar A, McCluskey J, Boston T.
    J Immunol; 1997 Sep 15; 159(6):2782-8. PubMed ID: 9300699
    [Abstract] [Full Text] [Related]

  • 2. T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II.
    Naujokas MF, Southwood S, Mathies SJ, Appella E, Sette A, Miller J.
    Cell Immunol; 1998 Aug 25; 188(1):49-54. PubMed ID: 9743557
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
    Mukherjee R, Chaturvedi P, Lee-Chan E, Singh B.
    Mol Immunol; 2008 Apr 25; 45(8):2166-76. PubMed ID: 18279957
    [Abstract] [Full Text] [Related]

  • 8. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
    Stebbins CC, Peterson ME, Suh WM, Sant AJ.
    J Immunol; 1996 Dec 01; 157(11):4892-8. PubMed ID: 8943393
    [Abstract] [Full Text] [Related]

  • 9. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB, Arndt SO, Hämmerling GJ, Kropshofer H.
    Semin Immunol; 1999 Dec 01; 11(6):391-403. PubMed ID: 10625593
    [Abstract] [Full Text] [Related]

  • 10. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S, Humphreys RE.
    Eur J Immunol; 1995 Jun 01; 25(6):1693-702. PubMed ID: 7614997
    [Abstract] [Full Text] [Related]

  • 11. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
    Eastman S, Deftos M, DeRoos PC, Hsu DH, Teyton L, Braunstein NS, Hackett CJ, Rudensky A.
    Eur J Immunol; 1996 Feb 01; 26(2):385-93. PubMed ID: 8617308
    [Abstract] [Full Text] [Related]

  • 12. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms.
    Bikoff EK, Kenty G, Van Kaer L.
    J Immunol; 1998 Apr 01; 160(7):3101-10. PubMed ID: 9531264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
    Yaneva R, Springer S, Zacharias M.
    Biopolymers; 2009 Jan 01; 91(1):14-27. PubMed ID: 18767126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.